Thoracic Surgery and Interventional Pulmonology Service, Helen F. Graham Cancer Center and Research Institute, Christiana Care Health System.
Division of Pulmonary and Critical Care Medicine, Rutgers New Jersey Medical School, NJ.
J Bronchology Interv Pulmonol. 2021 Oct 1;28(4):272-280. doi: 10.1097/LBR.0000000000000754.
Iatrogenic pneumothorax complicates transbronchial biopsies with a prevalence of 1% to 6%. Conventional treatment consists of inpatient management with chest tube drainage. While aspiration techniques have been investigated in the management of both primary spontaneous and transthoracic lung biopsy-induced pneumothorax, its role in the management of transbronchial biopsy-iatrogenic pneumothorax (TBBX-IP) is undefined. An appealing treatment alternative for TBBX-IP may exist in the placement of a small bore chest tube (SBCT) followed by a manual aspiration (MA) technique promoting earlier SBCT removal to facilitate outpatient management. To our knowledge, no study exists evaluating the efficacy of MA via a SBCT performed specifically for TBBX-IP.
Prospective evaluation of the efficacy of a protocolized pathway incorporating MA through a SBCT for the outpatient management of TBBX-IP. Primary outcome was the clinicoradiographic resolution of TBBX-IP avoiding hospitalizations.
A total of 763 biopsies performed; 31 complicated by TBBX-IP, 18 qualified for intervention. Sixteen were outpatients, 2 inpatients. Thirteen (81.25%) of the 16 outpatients were successfully treated with MA via SBCT and did not require admission. Twelve (75%) of these 13 had SBCT removed, 1 patient was discharged with SBCT and removed in 24 hours. Of the 18 patients requiring intervention, 13 (72.2%) were successfully treated with MA via SBCT enabling removal of SBCT. No patient required reintervention.
MA via SBCT represents a safe and viable management approach of TBBX-IP promoting earlier SBCT removal and decreased hospitalizations. Our results challenge conventional management of TBBX-IP warranting further investigation.
医源性气胸是经支气管活检的并发症,发生率为 1%至 6%。传统的治疗方法包括住院管理和胸腔引流。虽然抽吸技术已被用于原发性自发性和经胸肺活检引起的气胸的治疗,但在经支气管活检引起的气胸(TBBX-IP)的治疗中的作用尚未确定。对于 TBBX-IP,一种有吸引力的治疗选择可能是放置小口径胸腔引流管(SBCT),然后进行手动抽吸(MA)技术,以促进更早地移除 SBCT,从而便于门诊管理。据我们所知,尚无研究评估专门用于 TBBX-IP 的 MA 通过 SBCT 的疗效。
前瞻性评估纳入 MA 经 SBCT 的方案对 TBBX-IP 门诊管理的疗效。主要结局是 TBBX-IP 的临床和影像学缓解,避免住院治疗。
共进行了 763 次活检,其中 31 次并发 TBBX-IP,18 次符合干预条件。16 例为门诊患者,2 例为住院患者。16 例门诊患者中,13 例(81.25%)通过 SBCT 进行 MA 成功治疗,无需住院。这 13 例中有 12 例(75%)SBCT 被移除,1 例患者带 SBCT 出院,24 小时内移除。在需要干预的 18 例患者中,13 例(72.2%)通过 SBCT 进行 MA 成功治疗,能够移除 SBCT。没有患者需要再次干预。
MA 通过 SBCT 代表了一种安全可行的 TBBX-IP 治疗方法,可促进更早地移除 SBCT 和减少住院治疗。我们的结果挑战了 TBBX-IP 的传统治疗方法,值得进一步研究。